Literature DB >> 2584406

Findings in lymph nodes of patients with germ cell tumours after chemotherapy and their relation to prognosis.

R J Zuk1, B J Jenkins, J E Martin, R T Oliver, S I Baithun.   

Abstract

One hundred and forty six patients with advanced germ cell testicular tumours (38 seminomas and 108 malignant teratomas) treated by combination chemotherapy were studied over 10 years. Most of the improvement seen was in patients with malignant teratoma undifferentiated. In the most recently treated patients (1984-1987) 75% of drug resistant cases were malignant teratoma intermediate compared with 26% in the series treated between 1978-1983. The microscopic features of 52 primary testicular tumours were compared with features seen in excised retroperitoneal lymph nodes after completion of chemotherapy. Primary malignant teratoma intermediate had a higher incidence of viable malignancy in the excised tissue than malignant teratoma undifferentiated. Mature teratoma or fibronecrotic tissue within resected tissue was associated with a good prognosis. If resection was complete patients with drug resistant malignant teratoma intermediate had a more favourable prognosis than drug resistant malignant teratoma undifferentiated. It is advised that retroperitoneal node dissection should be considered in the management of patients with advanced germ cell testicular tumours, and that as complete a resection as possible be attempted to avoid the danger of missing residual disease.

Entities:  

Mesh:

Year:  1989        PMID: 2584406      PMCID: PMC501863          DOI: 10.1136/jcp.42.10.1049

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Radical retroperitoneal node dissection after chemotherapy for testicular tumours.

Authors:  S N Williams; B J Jenkins; S I Baithun; R T Oliver; J P Blandy
Journal:  Br J Urol       Date:  1989-06

2.  Testicular germ cell tumours--a model for a new approach to treatment of adult solid tumours.

Authors:  R T Oliver
Journal:  Postgrad Med J       Date:  1985-02       Impact factor: 2.401

3.  Comparison of histologic types of primary testicular germ cell tumors with their metastases: consequences for the WHO and the British Nomenclatures?

Authors:  W Bär; C Hedinger
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-04-05

4.  Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy.

Authors:  J P Donohue; L M Roth; J M Zachary; R G Rowland; L H Einhorn; S G Williams
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

5.  Loss of ejaculation following bilateral retroperitoneal lymphadenectomy.

Authors:  E Leiter; H Brendler
Journal:  J Urol       Date:  1967-09       Impact factor: 7.450

6.  Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction.

Authors:  L H Einhorn; S D Williams; I Mandelbaum; J P Donohue
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

Review 7.  Current dilemmas in the management of non-seminomatous germ cell tumors of the testis.

Authors:  C Williams
Journal:  Cancer Treat Rev       Date:  1977-12       Impact factor: 12.111

8.  The growing teratoma syndrome.

Authors:  C J Logothetis; M L Samuels; A Trindade; D E Johnson
Journal:  Cancer       Date:  1982-10-15       Impact factor: 6.860

9.  The biological and clinical significance of HCG-containing cells in seminoma.

Authors:  D N Butcher; W M Gregory; P A Gunter; J R Masters; M C Parkinson
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

10.  Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma.

Authors:  D Tait; M J Peckham; W F Hendry; P Goldstraw
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.